Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Obstetrics and Gynaecology
  • Obstetrics and Gynaecology Perspective
  • "Recurrent...

"Recurrent implantation failure - It's time to get personal"

Written By : Dr Nirali Kapoor |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2022-03-02T09:00:41+05:30  |  Updated On 2 March 2022 3:11 PM IST
Recurrent implantation failure - Its time to get personal
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Recurrent implantation failure (RIF) is a controversial and poorly understood diagnostic dilemma. It can be defined as a failed embryo implantation, where b-human chorionic gonadotropin is in the negative range after a certain number of embryo transfers. The term ''implantation failure'' should be reserved for this specific scenario rather than for early failed biochemical pregnancies that may have a different underlying etiology. Although the concept of recurrence clearly implies repeated failed embryo implantation, the precise number of failed transfers to be classified as RIF is not well established. It is apparent that a cleavage-stage embryo produced by a 45-year-old woman would have a drastically different chance of implantation compared with a top-quality blastocyst from a 32-year-old woman. Therefore, a simple number of failed transfer attempts, without incorporating individual patient and embryo characteristics, is likely to grossly exaggerate the prevalence of RIF, especially in older adults and patients with poor prognosis. This overestimation of the true prevalence of RIF has serious consequences that hamper future research efforts and, most importantly, result in patients and clinicians utilizing unproven and mostly unnecessary tests and interventions, of which some may be detrimental to the overall chance of pregnancy.

The basic question that must be asked is ''after how many transfers is a recurrent failure to implant more likely due to some unrecognized underlying pathology, rather than chance alone?'' In the issue of the journal Fertility and Sterility, Ata et al. pose this crucial question and endeavor to answer it on the basis of an embryo's euploidy status. They postulate that the diagnosis of RIF should be made once recurrent failure of embryos to implant is unlikely to be due to embryo aneuploidy. They use the concept of ''cumulative implantation probability,'' which is similar to the one we proposed recently, termed ''theoretical cumulative implantation rate''. The basic concept behind their model is rather elegant in its simplicity: if 50% of embryos at a certain female age are euploid and a euploid embryo has a 50% chance of implantation, then it follows that an untested embryo produced at this age has a 25% chance of implantation. The next step in their model is to estimate how many embryos with this probability of implantation would be required (cumulative implantation probability) to achieve a certain threshold, beyond which RIF can be diagnosed.

The investigators provided not only the theoretical justification for their model but also a user-friendly calculator, which estimates the cumulative implantation probability on the basis of 3 inputs: age of the patient, euploidy rate at this age, and the probability of implantation per euploid embryo. The output of this calculator, based on the underlying assumptions of the model, determines whether a patient should be diagnosed with RIF based on the predeterminant cumulative implantation probability threshold value, which can also be entered, if desired. The result is a simple and extremely valuable tool which has enormous potential to rationalize the definition and diagnosis of RIF and invigorate the entire spectrum of research and possible treatment of this common condition.

There is, however, one major shortcoming of this model that must be addressed before its widespread use can be recommended. It is obvious that the model's reliance on the assumed euploidy rate is problematic. It is well-recognized that the euploidy rate is mostly determined by the female's age, but it is not the only factor. There are recognized variations from patient to patient, from cycle to cycle in the same patient, and even between laboratories. There are also well-articulated concerns regarding reliance on genetic testing of embryos and their presumed euploidy, where it appears that the indiscriminate use of preimplantation genetic testing for aneuploidy (PGT-A) may be detrimental to the cumulative pregnancy rate per cycle started. Furthermore, although euploidy may be the main factor that determines the implantation potential of an embryo, it is not the only one. Other embryonic characteristics, such as its grade and thaw survival, may also be important. Endometrial factors and hormonal milieu cannot be ignored as they also play a crucial role in implantation.

It is apparent that for implantation to be successful, all stars need to align: an embryo must be at least potentially euploid and structurally capable of implantation, the endometrium must be receptive to such an embryo, there must be no interference with the initial communication between an embryo and the endometrium so that the process of implantation can proceed unhindered, and the hormonal intrauterine environment must be able to nourish an embryo during this process. Therefore, authors propose that a more versatile and realistic model dispense with reliance on the presumed euploidy rate, and instead be based purely on the chance of implantation per embryo, irrespective and not dependent on its euploidy status.

Reliance on predeterminant euploidy rate in the calculation of the cumulative implantation probability introduces an additional level of uncertainty that is neither necessary nor required. Clearly, the implantation rates of qualitatively different untested embryos, as well as the tested ones, will vary greatly, and the estimation of the cumulative implantation probability should be based on local outcomes, rather than published rates that may overestimate the chance of a positive result.

There is one last point that needs to be briefly discussed: the threshold at which the diagnosis of RIF should be entertained. The cumulative implantation probability at which RIF is diagnosed could be set in a variety of ways, including 80%, which is similar to the diagnosis of infertility itself, or by incorporating some form of statistical measure, such as the standard deviation. Authors believe that this issue is of great importance and may require an expert panel discussion or a workshop to reach a robust and clinically meaningful consensus.

The management of imprecisely defined RIF poses a major clinical challenge. Finally, new avenues toward standardized and personalized definitions are being explored, which will enhance clinical decision making, patient counseling, and future research in this area.

Source: Alex Polyakov, Fertility and Sterility VOL. 116 NO. 5
https://doi.org/10.1016/j.fertnstert.2021.08.031


Recurrent implantation failureInfertility
Source : Fertility and Sterility
Dr Nirali Kapoor
Dr Nirali Kapoor

    MBBS, MD Obstetrics and Gynecology

    Dr Nirali Kapoor has completed her MBBS from GMC Jamnagar and MD Obstetrics and Gynecology from AIIMS Rishikesh. She underwent training in trauma/emergency medicine non academic residency in AIIMS Delhi for an year after her MBBS. Post her MD, she has joined in a Multispeciality hospital in Amritsar. She is actively involved in cases concerning fetal medicine, infertility and minimal invasive procedures as well as research activities involved around the fields of interest.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    ABYSS Trial Finds Elevated BP, HR & Deleterious CV Outcomes After Beta blocker Withdrawal Post-MI: EuroPCR 2025 Update

    ABYSS Trial Finds Elevated BP, HR & Deleterious CV Outcomes After Beta blocker Withdrawal Post-MI:...

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    View All

    Journal Club Today

    Study Unveils Molecular Links between Air Pollution and Negative Birth Outcomes

    Study Unveils Molecular Links between Air Pollution and Negative Birth Outcomes

    View All

    Health News Today

    Health Bulletin 05/June/2025

    Health Bulletin 05/June/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok